Inspire Veterinary Partners, Inc. (IVP)
USD 0.19
(-4.48%)
USD 0.19
(-4.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -3.82 Million | -2.65 Million | -1 Million | -5520.00 |
| Net Income | -14.79 Million | -4.91 Million | -1.33 Million | -5520.00 |
| Depreciation & Amortization | 1.41 Million | 609.58 Thousand | 83.9 Thousand | - |
| Deferred income taxes | -397.89 Thousand | -216.25 Thousand | -9167.00 | - |
| Stock-based compensation | 397.89 Thousand | 216.25 Thousand | 9167.00 | - |
| Change in working capital | 2.95 Million | 548.81 Thousand | 216.15 Thousand | - |
| Other non-cash items | 6.59 Million | 1.09 Million | 21.04 Thousand | - |
| Investing Cash Flow | -1.86 Million | -14.66 Million | -4.02 Million | - |
| Investments in PPE | -383.72 Thousand | -176.79 Thousand | -1.31 Million | - |
| Acquisitions | -1.48 Million | -14.51 Million | -2.65 Million | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | - | 21.79 Thousand | -51.25 Thousand | - |
| Financing Cash Flow | 5.62 Million | 15.71 Million | 7.06 Million | 269.16 Thousand |
| Debt repayment | -185.43 Thousand | -494.03 Thousand | -1.24 Million | - |
| Dividends payments | -271.24 Thousand | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 5.43 Million | - | 385 Thousand | - |
| Other Financing Activities | 1.00 | 16.2 Million | 7.92 Million | 269.16 Thousand |
| Accounts receivables | 125.62 Thousand | -233.89 Thousand | -35.98 Thousand | - |
| Accounts payables | 2.18 Million | 974.04 Thousand | 44.89 Thousand | - |
| Inventory | 84.91 Thousand | -230.12 Thousand | -41 Thousand | - |
| Other working capital | 561.62 Thousand | 38.79 Thousand | 248.24 Thousand | - |
| Cash at beginning of period | 444.25 Thousand | 2.05 Million | 21.97 Thousand | - |
| Cash at end of period | 178.96 Thousand | 444.25 Thousand | 2.05 Million | 263.64 Thousand |
| Capital Expenditure | -383.72 Thousand | -176.79 Thousand | -1.31 Million | - |
| Effect of forex changes on cash | -200 Thousand | - | - | - |
| Net cash flow / Change in cash | -265.29 Thousand | -1.61 Million | 2.03 Million | 263.64 Thousand |
| Free Cash Flow | -4.2 Million | -2.83 Million | -2.32 Million | -5520.00 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.38 Million | -3.42 Million | -14.79 Million | -4.14 Million | -7.88 Million | -1.22 Million |
| Depreciation & Amortization | 553.89 Thousand | 401.21 Thousand | 1.41 Million | 382.22 Thousand | 342.19 Thousand | 332.89 Thousand |
| Deferred income taxes | - | - | -397.89 Thousand | -197.29 Thousand | -197.89 Thousand | - |
| Stock-based compensation | - | 286.69 Thousand | 397.89 Thousand | 197.29 Thousand | 197.89 Thousand | - |
| Change in working capital | 1.51 Million | -2.17 Million | 2.95 Million | 1.54 Million | 426.45 Thousand | 435.99 Thousand |
| Other non-cash items | 2.1 Million | 2.77 Million | 6.59 Million | 1.46 Million | 4.55 Million | 261.4 Thousand |
| Investing Cash Flow | -23.69 Thousand | -156.94 Thousand | -1.86 Million | -1.5 Million | -240.55 Thousand | -109.54 Thousand |
| Investments in PPE | -23.69 Thousand | -156.94 Thousand | -383.72 Thousand | -19.63 Thousand | -240.55 Thousand | -109.54 Thousand |
| Acquisitions | - | - | -1.48 Million | -1.48 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 4016.00 | - | -4016.00 |
| Financing Cash Flow | -187.44 Thousand | 3.21 Million | 5.62 Million | 682.78 Thousand | 3.89 Million | 576.36 Thousand |
| Debt repayment | -187.44 Thousand | -159.36 Thousand | -185.43 Thousand | -682.78 Thousand | -2.05 Million | -423.63 Thousand |
| Dividends payments | - | -92.32 Thousand | -271.24 Thousand | -271.24 Thousand | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 3.37 Million | 5.43 Million | -5.04 Million | 5.43 Million | - |
| Other Financing Activities | - | 3.57 Million | 1.00 | -286.44 Thousand | 507.46 Thousand | 1 Million |
| Accounts receivables | 301.76 Thousand | -280.39 Thousand | 125.62 Thousand | 57.02 Thousand | -142.41 Thousand | -28.66 Thousand |
| Accounts payables | 196.2 Thousand | 315.16 Thousand | 2.18 Million | 905.14 Thousand | 204.06 Thousand | 528.41 Thousand |
| Inventory | -28.93 Thousand | 25.85 Thousand | 84.91 Thousand | 183.2 Thousand | 21.56 Thousand | -101.39 Thousand |
| Other working capital | 896.2 Thousand | -2.23 Million | 561.62 Thousand | 395.57 Thousand | 343.24 Thousand | 37.64 Thousand |
| Cash at beginning of period | 69.07 Thousand | 178.96 Thousand | 444.25 Thousand | 1.95 Million | 863.17 Thousand | 593.86 Thousand |
| Cash at end of period | 7658.00 | 69.07 Thousand | 178.96 Thousand | 178.96 Thousand | 1.95 Million | 863.17 Thousand |
| Capital Expenditure | -23.69 Thousand | -156.94 Thousand | -383.72 Thousand | -19.63 Thousand | -240.55 Thousand | -109.54 Thousand |
| Effect of forex changes on cash | - | - | -200 Thousand | -200 Thousand | - | - |
| Net cash flow / Change in cash | -61.41 Thousand | -109.88 Thousand | -265.29 Thousand | -1.77 Million | 1.09 Million | 269.31 Thousand |
| Free Cash Flow | 126.02 Thousand | -3.32 Million | -4.2 Million | -774.41 Thousand | -2.79 Million | -307.05 Thousand |
PCTY
MEDX
ALD
2404
2750
BPPPF